Alembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg.
Mumbai 5th September, 2024: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Albendazole Tablets USP, 200 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), LAlbenza Tablets, 200 mg, of Impax Laboratories, Inc. (Impax).
Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium. It is also indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus. Refer label for a detailed indication.
Alembic has a cumulative total of 214 ANDA approvals (186 final approvals and 28 tentative approvals) from USFDA.
More Stories
Desperate Plea: Blood Stem Cell Donors Needed to Save Three Siblings
Mumbai/thiruvalla, January 20, 2025: In a difficult battle for survival, three young siblings from Kottayam – Faizy (11), Faiha (10),...
The Dark Side of Bodybuilding: Rising Risks of Steroid Hormone Abuse
Dr. Manjunath Malige, Director - Diabetes and Endocrinology, Sakra World Hospital, Bengaluru The pursuit of physical perfection has become an...
Breaking Ground: India Performs First Robotic Nipple-Sparing Mastectomy with Tiloop Reconstruction
[caption id="attachment_289512" align="aligncenter" width="786"] Mr. Dinesh Madhavan, President of Group Oncology and International at Apollo Hospitals Enterprise Ltd (AHEL), Dr....
NU Hospitals and MedLern Collaborate to Achieve Zero Hepatitis C in Dialysis Care
New Delhi, 16th January 2025: NU Hospitals, a pioneer in nephrology and urology care, has achieved a groundbreaking milestone in...
Protect Your Health: Uncovering the Hidden Natural Toxins in Everyday Foods
By, Soumita Biswas, Clinical Nutritionist, Aster RV Hospital Natural toxins in food are a hidden yet significant concern, capable of...
Malaysian Software Engineer Undergoes Advanced Robotic Hip Surgery at Fortis Bannerghatta
Bangalore, 16th January 2025: Fortis Hospital Bannerghatta Road, has successfully treated a 53-year-old software engineer from Malaysia who underwent a...